Learn More
Medchemexpress LLC ENMD-2076 Tartrate | 1453868-32-0 | 99.66% | 525.56 | 50 MG

Supplier: Medchemexpress LLC HY1098710MG
ENMD-2076 Tartrate is a multi-targeted kinase inhibitor primarily targeting Aurora A, Flt3, and VEGFR2. It is intended for research use only and not for patient applications. This compound is known for its inhibitory effects on various kinases, contributing to its potential in anti-proliferative and anti-angiogenic research.
- Exhibits potent inhibition of Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, and PDGFRα.
- Induces G2-M-phase arrest and apoptosis in U937 cells.
- Inhibits Flt3 and Kit autophosphorylation.
- Shows dose-dependent inhibition of tumor growth in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.